Recalls / —
—#179021
Product
Portex LineDraw Arterial Blood Sampling Syringe with Dry Lithium Heparin for Gases and Electrolytes
- FDA product code
- JKA — Tubes, Vials, Systems, Serum Separators, Blood Collection
- Device class
- Class 2
- Medical specialty
- Clinical Chemistry
- 510(k) numbers
- K952516
- Affected lot / code info
- Portex LineDraw Arterial Blood Sampling Syringe: Item Number Lot Number 4042-2 3848838 4042-2 3848878 4042-2 3856950 4042-2 3859774 4042LH 3856958 4042LH 3859747
Why it was recalled
Portex Pro-Vent and LineDraw Arterial Blood Sampling syringes may have broken luers.
Root cause (FDA determination)
Process control
Action the firm took
The firm initiated the recall by letter on January 07, 2020. The "Urgent Medical Device Recall Notice", identified the removal of devices and instructed the customer to quarantine the affected products. The Notice provided the accompanying Recall Response Form to be completed and returned within 10 days of receipt to smithmedical4136@stericycle.com. The Notice details that the affected product must be returned to Stericycle for processing. The Notice instructed the distributor to notify their customers and to provide the customer a copy of the Recall Notice and Response Form. The Notice provided the contact email smithmedical4136@stericycle.com and phone number of 8669188738 for assistance.
Recalling firm
- Firm
- Smiths Medical ASD, Inc.
- Address
- 10 Bowman Dr, Keene, New Hampshire 03431-5043
Distribution
- Distribution pattern
- USA: AL, AR, AZ, CA, CO, FL, GA, IA, ID, IL, IN, KS, LA, MA, MD, MI,MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA. Int'l: CA, DE, AU.
Timeline
- Recall initiated
- 2020-01-07
- Posted by FDA
- 2020-04-15
- Terminated
- 2020-12-14
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #179021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.